At last, a drug to slow down Alzheimer's

Eisai Co, a Tokyo-based pharmaceutical company with a family bent and market capitalisation of $14 billion, crossed the finish line before behemoths valued nearly 20-fold higher, including industry leaders Roche Holding AG and Eli Lilly & Co

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3Xoux8i
via IFTTT